Published in J Mater Sci Mater Med on April 20, 2012
Highly biocompatible behaviour and slow degradation of a LDH (layered double hydroxide)-coating on implants in the middle ear of rabbits. J Mater Sci Mater Med (2015) 0.77
Accessing the biocompatibility of layered double hydroxide by intramuscular implantation: histological and microcirculation evaluation. Sci Rep (2016) 0.75
Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials (2005) 1.72
Intercalation compounds of hydrotalcite-like anionic clays with antiinflammatory agents--I. Intercalation and in vitro release of ibuprofen. Int J Pharm (2001) 1.26
Intercalation compounds of hydrotalcite-like anionic clays with anti-inflammatory agents, II: Uptake of diclofenac for a controlled release formulation. AAPS PharmSciTech (2002) 1.21
A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units. Am J Infect Control (2008) 1.08
Intercalation of hydrophilic and hydrophobic antibiotics in layered double hydroxides. Int J Pharm (2006) 1.07
Tackling antibiotic resistance: a dose of common antisense? J Antimicrob Chemother (2008) 1.02
Anionic clays containing anti-inflammatory drug molecules: comparison of molecular dynamics simulation and measurements. J Phys Chem B (2005) 0.97
Vancomycin and meropenem in acrylic cement: elution kinetics of in vitro bactericidal action. Chir Organi Mov (2008) 0.81
Immobilization of ibuprofen and copper-ibuprofen drugs on layered double hydroxides. J Pharm Sci (2005) 0.80
Clusterin antisense complexed with chitosan for controlled intratumoral delivery. Int J Pharm (2007) 0.80
The antacid Talcid adsorbs and neutralizes all proteins secreted by H. pylori including VacA cytotoxin: a new mechanism for its ulcer-healing action? Digestion (1999) 0.76
Drug intercalation in layered double hydroxide clay: application in the development of a nanocomposite film for guided tissue regeneration. Int J Pharm (2011) 0.76
The use of bone cement for the localized, controlled release of the antibiotics vancomycin, linezolid, or fusidic acid: effect of additives on drug release rates and mechanical strength. Drug Deliv Transl Res (2011) 0.76
Prospects for antisense agents in the therapy of bacterial infections. Expert Opin Investig Drugs (1999) 0.75
Controlled release of alendronate from polymeric films. J Biomater Sci Polym Ed (2009) 0.75
Nanohybrids for controlled antibiotic release in topical applications. Int J Antimicrob Agents (2007) 0.75
Terrestrial and aquatic invertebrates as bioindicators for environmental monitoring, with particular reference to mountain ecosystems. Environ Manage (2005) 1.50
Riparian deforestation, stream narrowing, and loss of stream ecosystem services. Proc Natl Acad Sci U S A (2004) 1.44
Polymeric drug delivery of platinum-based anticancer agents. J Pharm Sci (2009) 1.13
On-demand controlled release of docetaxel from a battery-less MEMS drug delivery device. Lab Chip (2011) 1.09
Drug-eluting stents: factors governing local pharmacokinetics. Adv Drug Deliv Rev (2006) 1.08
Copolymer micelles and nanospheres with different in vitro stability demonstrate similar paclitaxel pharmacokinetics. Mol Pharm (2012) 0.97
Mosquirix (RTS,S): a novel vaccine for the prevention of Plasmodium falciparum malaria. Ann Pharmacother (2012) 0.94
The inhibition of collagenase induced degradation of collagen by the galloyl-containing polyphenols tannic acid, epigallocatechin gallate and epicatechin gallate. J Mater Sci Mater Med (2010) 0.93
Transparent films based on PLA and montmorillonite with tunable oxygen barrier properties. Biomacromolecules (2012) 0.92
Methotrexate loaded poly(L-lactic acid) microspheres for intra-articular delivery of methotrexate to the joint. J Pharm Sci (2004) 0.91
A magnetically controlled MEMS device for drug delivery: design, fabrication, and testing. Lab Chip (2011) 0.91
In vitro chelating, cytotoxicity, and blood compatibility of degradable poly(ethylene glycol)-based macromolecular iron chelators. Biomaterials (2008) 0.90
Fusidic acid and rifampicin co-loaded PLGA nanofibers for the prevention of orthopedic implant associated infections. J Control Release (2013) 0.90
Paclitaxel loaded poly(L-lactic acid) (PLLA) microspheres. II. The effect of processing parameters on microsphere morphology and drug release kinetics. Int J Pharm (2004) 0.89
Pharmacokinetic study of methotrexate following intra-articular injection of methotrexate loaded poly(L-lactic acid) microspheres in rabbits. J Pharm Sci (2005) 0.88
Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models. Cancer Chemother Pharmacol (2005) 0.86
In vivo evaluation of mucoadhesive nanoparticulate docetaxel for intravesical treatment of non-muscle-invasive bladder cancer. Clin Cancer Res (2011) 0.85
The use of tissue sealants to deliver antibiotics to an orthopaedic surgical site with a titanium implant. J Orthop Sci (2012) 0.84
Effects of continuous and pulsatile PTH treatments on rat bone marrow stromal cells. Biochem Biophys Res Commun (2009) 0.84
Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer. BJU Int (2008) 0.84
Phase separation behavior of fusidic acid and rifampicin in PLGA microspheres. Mol Pharm (2012) 0.83
An in vitro study of plasticized poly(lactic-co-glycolic acid) films as possible guided tissue regeneration membranes: material properties and drug release kinetics. J Biomed Mater Res A (2010) 0.83
Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer. BJU Int (2008) 0.83
A preliminary report on the effects of paclitaxel-impregnated stents on sheep nasal mucosa. Am J Rhinol (2004) 0.83
Hyperbranched polymers for controlled release of cisplatin. Dalton Trans (2008) 0.83
Paclitaxel incorporated in hydrophobically derivatized hyperbranched polyglycerols for intravesical bladder cancer therapy. BJU Int (2008) 0.83
Characterization of perivascular poly(lactic-co-glycolic acid) films containing paclitaxel. Int J Pharm (2004) 0.83
Paclitaxel-loaded crosslinked hyaluronic acid films for the prevention of postsurgical adhesions. Pharm Res (2002) 0.82
Methoxypolyethylene glycol-block-polycaprolactone diblock copolymers reduce P-glycoprotein efflux in the absence of a membrane fluidization effect while stimulating P-glycoprotein ATPase activity. J Pharm Sci (2007) 0.82
Composite films of arabinoxylan and fibrous sepiolite: morphological, mechanical, and barrier properties. ACS Appl Mater Interfaces (2012) 0.82
PLGA and PHBV microsphere formulations and solid-state characterization: possible implications for local delivery of fusidic acid for the treatment and prevention of orthopaedic infections. Pharm Res (2009) 0.82
Sustainable films and coatings from hemicelluloses: a review. Biomacromolecules (2008) 0.81
Effect of the UGT1A1*28 allele on unconjugated hyperbilirubinemia in HIV-positive patients receiving Atazanavir: a systematic review. Ann Pharmacother (2013) 0.81
The differential in vitro and in vivo responses of bone marrow stromal cells on novel porous gelatin-alginate scaffolds. J Tissue Eng Regen Med (2009) 0.81
The inhibition of angiogenesis by antisense oligonucleotides to clusterin. Angiogenesis (2005) 0.81
Increased accumulation of paclitaxel and doxorubicin in proliferating capillary cells and prostate cancer cells following ultrasound exposure. Ultrasonics (2011) 0.81
The use of nanocrystalline cellulose for the binding and controlled release of drugs. Int J Nanomedicine (2011) 0.80
A review of the pharmacokinetic implications of schistosomiasis. Clin Pharmacokinet (2013) 0.80
Clusterin antisense complexed with chitosan for controlled intratumoral delivery. Int J Pharm (2007) 0.80
P-glycoprotein efflux inhibition by amphiphilic diblock copolymers: relationship between copolymer concentration and substrate hydrophobicity. Mol Pharm (2008) 0.80
The combined use of paclitaxel-loaded nanoparticles with a low-molecular-weight copolymer inhibitor of P-glycoprotein to overcome drug resistance. Int J Nanomedicine (2013) 0.80
Determining the critical micelle concentration of a novel lipid-lowering agent, disodium ascorbyl phytostanyl phosphate (FM-VP4), using a fluorescence depolarization procedure. Drug Dev Ind Pharm (2004) 0.80
The characterization of novel polymeric paste formulations for intratumoral delivery. Int J Pharm (2004) 0.79
Synthesis and characterization of carboxylic acid conjugated, hydrophobically derivatized, hyperbranched polyglycerols as nanoparticulate drug carriers for cisplatin. Biomacromolecules (2010) 0.79
Paclitaxel-loaded poly(L-lactic acid) microspheres 3: blending low and high molecular weight polymers to control morphology and drug release. Int J Pharm (2004) 0.79
In vitro and in vivo evaluation of intravesical docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols in an orthotopic model of bladder cancer. Biomacromolecules (2011) 0.78
Fabrication of robust hydrogel coatings on polydimethylsiloxane substrates using micropillar anchor structures with chemical surface modification. ACS Appl Mater Interfaces (2014) 0.78
The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers. Int J Pharm (2007) 0.78
The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors. Cancer Chemother Pharmacol (2007) 0.78
Use of fibrin sealants for the localized, controlled release of cefazolin. Can J Surg (2006) 0.78
Intra-articular treatment of inflammatory arthritis with microsphere formulations of methotrexate: pharmacokinetics and efficacy determination in antigen-induced arthritic rabbits. Inflamm Res (2009) 0.77
Tissue uptake of docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols and their effects on the morphology of the bladder urothelium. Biomaterials (2011) 0.77
Mixed molecular weight copolymer nanoparticles for the treatment of drug-resistant tumors: formulation development and cytotoxicity. J Pharm Sci (2014) 0.77
Calcium pyrophosphate dihydrate crystal associated induction of neutrophil activation and repression of TNF-alpha-induced apoptosis is mediated by the p38 MAP kinase. Cell Signal (2004) 0.77
Calcium pyrophosphate dihydrate crystal-induced inhibition of neutrophil apoptosis: involvement of Bcl-2 family members. Inflamm Res (2009) 0.77
Increased accumulation and retention of micellar paclitaxel in drug-sensitive and P-glycoprotein-expressing cell lines following ultrasound exposure. Ultrasound Med Biol (2012) 0.77
Same-single-cell analysis using the microfluidic biochip to reveal drug accumulation enhancement by an amphiphilic diblock copolymer drug formulation. Anal Bioanal Chem (2014) 0.76
Drug intercalation in layered double hydroxide clay: application in the development of a nanocomposite film for guided tissue regeneration. Int J Pharm (2011) 0.76
Abandoned coal mine drainage and its remediation: impacts on stream ecosystem structure and function. Ecol Appl (2012) 0.75
Amphiphilic dextran-graft-poly(epsilon-caprolactone) films for the controlled release of paclitaxel. Int J Pharm (2004) 0.75
Controlled release of alendronate from polymeric films. J Biomater Sci Polym Ed (2009) 0.75
Carbohydrate analysis of hemicelluloses by gas chromatography-mass spectrometry of acetylated methyl glycosides. Anal Bioanal Chem (2012) 0.75
Use of hydrodynamic flow focusing for the generation of biodegradable camptothecin-loaded polymer microspheres. J Pharm Sci (2008) 0.75
The solid-state characterization of fusidic acid. Int J Pharm (2011) 0.75
Unimolecular micelles based on hydrophobically derivatized hyperbranched polyglycerols: ligand binding properties. Biomacromolecules (2008) 0.75
Janus ultrathin film from multi-level self-assembly at air-water interfaces. Chem Commun (Camb) (2014) 0.75
The encapsulation of ribozymes in biodegradable polymeric matrices. Int J Pharm (2002) 0.75